Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-Decoction for allergic rhinitis.
Study Design
- Studientyp
- Other
- Population
- None
- Intervention
- Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-Decoction for allergic rhinitis. None
- Vergleichsgruppe
- None
- Primärer Endpunkt
- None
- Wirkungsrichtung
- Mixed
- Verzerrungsrisiko
- Unclear
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Allergic rhinitis (AR) is one of most prevalent disease and it is urgent need to develop new drug. Tuomin-Zhiti-Decoction (TZD) is a traditional medicinal compound consisting of eleven different herbs and has a significant effect on AR, yet its underlying mechanism is still unknown. AIM OF THE STUDY: The aim of this study was to confirm the anti-AR effects and the underlying mechanism of TZD. Integrative analysis of network pharmacology and proteomics to explore the common mechanism of TZD treating AR. MATERIALS AND METHODS: Mice were subjected to serial intranasal challenge with ovalbumin (OVA), we examinaed the nasal symptoms, histopathology and Th1/Th2-related cytokines after TZD treatments. Active compounds, potential targets and underlying mechanisms of TZD against AR were systematically clarified by integrating network pharmacology and proteomics analysis. Then we validated the binding affinity between the key potential targets and matching active compounds using molecular docking evaluation. RESULTS: TZD controlled allergy by reduction of OVA-specific immunoglobulin E (IgE) and histamine release. In nasal tissue, TZD decreased nasal rubbing, sneezing and reduced AR-induced damage to nasal mucosa, accordingly, the nasal symptoms were also clearly ameliorated. Moreover, TZD modulated the balance of Th1/Th2/Th17. The proteomics analysis recognized 41 differentially expressed proteins (DEPs). Integrative analysis of network pharmacology and proteomics, we found IL-6 and CD40 could be potential protein targets of TZD against AR, quercetin and wogonin may play more effective roles in AR. Active core compounds of TZD could bind closely to the key targets by molecular docking. CONCLUSION: TZD may have therapeutic potential for treating AR, integrating analysis of network pharmacology and proteomics uncovered the underlying mechanism and targets of TZD, which provides a scientific method for the sensible development of traditional Chinese medicine.
Zusammenfassung
TZD may have therapeutic potential for treating AR, and integrating analysis of network pharmacology and proteomics uncovered the underlying mechanism and targets of TZD, which provides a scientific method for the sensible development of traditional Chinese medicine.
Used In Evidence Reviews
Similar Papers
Molecules (Basel, Switzerland) · 2016
Quercetin and Its Anti-Allergic Immune Response.
The Journal of allergy and clinical immunology · 2009
Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
Quercetin with the potential effect on allergic diseases.
Autoimmunity · 2023
Quercetin improves the imbalance of Th1/Th2 cells and Treg/Th17 cells to attenuate allergic rhinitis.
Primary care · 2002
Respiratory and allergic diseases: from upper respiratory tract infections to asthma.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2004